Compare TXG & CLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | CLBT |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | Israel |
| Employees | N/A | 1285 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.2B |
| IPO Year | 2019 | N/A |
| Metric | TXG | CLBT |
|---|---|---|
| Price | $34.68 | $12.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | $20.25 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 3.2M | 1.8M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $245,893,000.00 | N/A |
| Revenue This Year | N/A | $21.45 |
| Revenue Next Year | $7.33 | $17.47 |
| P/E Ratio | ★ N/A | $45.29 |
| Revenue Growth | ★ 68.06 | N/A |
| 52 Week Low | $11.17 | $11.03 |
| 52 Week High | $35.65 | $19.98 |
| Indicator | TXG | CLBT |
|---|---|---|
| Relative Strength Index (RSI) | 70.67 | 45.24 |
| Support Level | $16.11 | $12.65 |
| Resistance Level | $35.65 | $13.95 |
| Average True Range (ATR) | 2.41 | 0.64 |
| MACD | 0.23 | -0.14 |
| Stochastic Oscillator | 91.84 | 15.68 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.